The fact that rearrangements at CTNND2 were only observed in clinically significant cases, and overexpression of δ-catenin is associated with worse prognosis strongly suggest that δ-catenin is a driver in PCa that promotes tumor progression by altering the cell cycle and stimulating cell growth of PCa [26]. The gene discussed is CTNND2; the disease is posterior cortical atrophy.